Previous close | 0.4000 |
Open | 0.3000 |
Bid | 0.1000 |
Ask | 0.5000 |
Strike | 5.00 |
Expiry date | 2024-05-17 |
Day's range | 0.3000 - 0.4000 |
Contract range | N/A |
Volume | |
Open interest | 96 |
CARLSBAD, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a biotechnology company developing treatments for serious degenerative genetic diseases, today announced that management will participate in a fireside chat at the 2024 RBC Capital Markets Healthcare Conference on Wednesday, May 15, 2024, at 11:30 a.m. ET in New York. A live webcast of the fireside chat will be available here and in the investors section of the company’s website at www.designtx.com. The
Whilst it may not be a huge deal, we thought it was good to see that the Design Therapeutics, Inc. ( NASDAQ:DSGN...
We can readily understand why investors are attracted to unprofitable companies. For example, although...